Application of dendritic cells in tumor immunotherapy and progress in the mechanism of anti-tumor effect of Astragalus polysaccharide (APS) modulating dendritic cells: a review
Authors:
Open Access
- 18 September 2022
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 155, 113541
Abstract
No abstract availableKeywords
This publication has 137 references indexed in Scilit:
- Deciphering the transcriptional network of the dendritic cell lineageNature Immunology, 2012
- Zbtb46expression distinguishes classical dendritic cells and their committed progenitors from other immune lineagesJournal of Experimental Medicine, 2012
- Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cellsJournal of Clinical Investigation, 2012
- Transforming growth factor beta-activated kinase 1 (TAK1)-dependent checkpoint in the survival of dendritic cells promotes immune homeostasis and functionProceedings of the National Academy of Sciences, 2012
- Mechanisms regulating dendritic cell specification and developmentImmunological Reviews, 2010
- Mammalian Target of Rapamycin Controls Dendritic Cell Development Downstream of Flt3 Ligand SignalingImmunity, 2010
- Dysfunctional DC subsets in RCC patients: Ex vivo correction to yield an effective anti-cancer vaccineMolecular Immunology, 2009
- Geography and plumbing control the T cell response to infectionImmunology & Cell Biology, 2008
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Differential Antigen Processing by Dendritic Cell Subsets in VivoScience, 2007